Recent years have brought transformative breakthroughs for people battling multiple myeloma. Clinical trials and regulatory approvals are ushering in more effective treatments, hope for longer remissions, and better quality of life for both newly diagnosed and relapsed/refractory patients.
Digital, hemato-oncology, Social Media Listening, Oncology
The ASH Annual Meeting & Exposition 2024 took place from December 7th to 10th, 2024, in San Diego,...
Digital, hemato-oncology, Social Media Listening, Oncology
The EHA 2024 (European Hematogoly Association) Hybrid Congress took place from June 13th to June...
Digital, hemato-oncology, Social Media Listening, Oncology
The 2024 ASCO annual meeting took place from May 31st to June 4th, 2024, in Chicago, Il, USA. This...
Digital, hemato-oncology, Social Media Listening, Oncology
The 65th ASH annual meeting and exposition took place on December 09-12, 2023, in San Diego,...
Digital, hemato-oncology, Social Media Listening, Oncology
The 2023 ESMO annual meeting took place from OCtober 20th to October 24 2023, in Madrid, Spain....
Digital, hemato-oncology, Social Media Listening, Oncology
The EHA2023 (European Hematogoly Association) Hybrid Congress took place from June 8th to June...
Digital, hemato-oncology, Social Media Listening, Oncology
The 2023 ASCO (American Society of Clinical Oncology) annual meeting took place from June 2nd to...
Digital, hemato-oncology, Social Media Listening, Oncology
The 64th ASH annual meeting and exposition took place on December 10-13, 2022 in New Orleans. The...
Digital, hemato-oncology, Social Media Listening, Oncology
The American Society of Clinical Oncology (ASCO) annual meeting is a flagship event in the global...